aluates Reports

$ 0.0

Automative

Global Dry Age-Related Macular Degeneration Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-13V10356

Global Dry Age Related Macular Degeneration Market Insights Forecast to 2028

BUY CHAPTERS

Global Dry Age-Related Macular Degeneration Market Research Report 2025

Code: QYRE-Auto-13V10356

Report

July 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Santen Pharmaceuticals

Allergan plc

Bausch Health

Alimera Science

Phio Pharmaceuticals

IVERIC bio

Stealth Biotherapeutics

Ocumension Therapeutics

Belite Bio

Kubota Vision

Eyestem Research

Y2 Solution

Dry Age-Related Macular Degeneration Market Size

The global market for Dry Age-Related Macular Degeneration was valued at US$ 1558 million in the year 2024 and is projected to reach a revised size of US$ 2407 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Dry Age-Related Macular Degeneration Market

Dry macular degeneration is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula (MAK-u-luh). The macula is the part of the retina responsible for clear vision in your direct line of sight.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Dry Age-Related Macular Degeneration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Age-Related Macular Degeneration.

The Dry Age-Related Macular Degeneration market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dry Age-Related Macular Degeneration market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dry Age-Related Macular Degeneration companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Dry Age-Related Macular Degeneration Market Report

Report Metric	Details
Report Name	Dry Age-Related Macular Degeneration Market
Accounted market size in year	US$ 1558 million
Forecasted market size in 2031	US$ 2407 million
CAGR	6.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Injectables
Segment by Application	Above 40 Years Above 60 Years Above 75 Years
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Santen Pharmaceuticals, Allergan, Bausch Health, Alimera Science, Phio Pharmaceuticals, Ocumension Therapeutics, Belite Bio, Kubota Vision, Iveric Bio, Eyestem Research, Y2 Solution, Stealth Biotherapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Age-Related Macular Degeneration company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Dry Age-Related Macular Degeneration Market growing?

Ans: The Dry Age-Related Macular Degeneration Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Dry Age-Related Macular Degeneration Market size in 2031?

Ans: The Dry Age-Related Macular Degeneration Market size in 2031 will be US$ 2407 million.

Who are the main players in the Dry Age-Related Macular Degeneration Market report?

Ans: The main players in the Dry Age-Related Macular Degeneration Market are Santen Pharmaceuticals, Allergan, Bausch Health, Alimera Science, Phio Pharmaceuticals, Ocumension Therapeutics, Belite Bio, Kubota Vision, Iveric Bio, Eyestem Research, Y2 Solution, Stealth Biotherapeutics

What are the Application segmentation covered in the Dry Age-Related Macular Degeneration Market report?

Ans: The Applications covered in the Dry Age-Related Macular Degeneration Market report are Above 40 Years, Above 60 Years, Above 75 Years

What are the Type segmentation covered in the Dry Age-Related Macular Degeneration Market report?

Ans: The Types covered in the Dry Age-Related Macular Degeneration Market report are Oral, Injectables

Recommended Reports

Macular Degeneration & Retina

Ophthalmic Drugs & Therapy

Eye Diagnostics & Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Injectables

1.3 Market by Application

1.3.1 Global Dry Age-Related Macular Degeneration Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Above 40 Years

1.3.3 Above 60 Years

1.3.4 Above 75 Years

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Dry Age-Related Macular Degeneration Market Perspective (2020-2031)

2.2 Global Dry Age-Related Macular Degeneration Growth Trends by Region

2.2.1 Global Dry Age-Related Macular Degeneration Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Dry Age-Related Macular Degeneration Historic Market Size by Region (2020-2025)

2.2.3 Dry Age-Related Macular Degeneration Forecasted Market Size by Region (2026-2031)

2.3 Dry Age-Related Macular Degeneration Market Dynamics

2.3.1 Dry Age-Related Macular Degeneration Industry Trends

2.3.2 Dry Age-Related Macular Degeneration Market Drivers

2.3.3 Dry Age-Related Macular Degeneration Market Challenges

2.3.4 Dry Age-Related Macular Degeneration Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Dry Age-Related Macular Degeneration Players by Revenue

3.1.1 Global Top Dry Age-Related Macular Degeneration Players by Revenue (2020-2025)

3.1.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Players (2020-2025)

3.2 Global Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Dry Age-Related Macular Degeneration Revenue

3.4 Global Dry Age-Related Macular Degeneration Market Concentration Ratio

3.4.1 Global Dry Age-Related Macular Degeneration Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Dry Age-Related Macular Degeneration Revenue in 2024

3.5 Global Key Players of Dry Age-Related Macular Degeneration Head office and Area Served

3.6 Global Key Players of Dry Age-Related Macular Degeneration, Product and Application

3.7 Global Key Players of Dry Age-Related Macular Degeneration, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Dry Age-Related Macular Degeneration Breakdown Data by Type

4.1 Global Dry Age-Related Macular Degeneration Historic Market Size by Type (2020-2025)

4.2 Global Dry Age-Related Macular Degeneration Forecasted Market Size by Type (2026-2031)

5 Dry Age-Related Macular Degeneration Breakdown Data by Application

5.1 Global Dry Age-Related Macular Degeneration Historic Market Size by Application (2020-2025)

5.2 Global Dry Age-Related Macular Degeneration Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Dry Age-Related Macular Degeneration Market Size (2020-2031)

6.2 North America Dry Age-Related Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Dry Age-Related Macular Degeneration Market Size by Country (2020-2025)

6.4 North America Dry Age-Related Macular Degeneration Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Dry Age-Related Macular Degeneration Market Size (2020-2031)

7.2 Europe Dry Age-Related Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Dry Age-Related Macular Degeneration Market Size by Country (2020-2025)

7.4 Europe Dry Age-Related Macular Degeneration Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Dry Age-Related Macular Degeneration Market Size (2020-2031)

8.2 Asia-Pacific Dry Age-Related Macular Degeneration Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Region (2020-2025)

8.4 Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Dry Age-Related Macular Degeneration Market Size (2020-2031)

9.2 Latin America Dry Age-Related Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Dry Age-Related Macular Degeneration Market Size by Country (2020-2025)

9.4 Latin America Dry Age-Related Macular Degeneration Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Dry Age-Related Macular Degeneration Market Size (2020-2031)

10.2 Middle East & Africa Dry Age-Related Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Country (2020-2025)

10.4 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Santen Pharmaceuticals

11.1.1 Santen Pharmaceuticals Company Details

11.1.2 Santen Pharmaceuticals Business Overview

11.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Introduction

11.1.4 Santen Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.1.5 Santen Pharmaceuticals Recent Development

11.2 Allergan

11.2.1 Allergan Company Details

11.2.2 Allergan Business Overview

11.2.3 Allergan Dry Age-Related Macular Degeneration Introduction

11.2.4 Allergan Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.2.5 Allergan Recent Development

11.3 Bausch Health

11.3.1 Bausch Health Company Details

11.3.2 Bausch Health Business Overview

11.3.3 Bausch Health Dry Age-Related Macular Degeneration Introduction

11.3.4 Bausch Health Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.3.5 Bausch Health Recent Development

11.4 Alimera Science

11.4.1 Alimera Science Company Details

11.4.2 Alimera Science Business Overview

11.4.3 Alimera Science Dry Age-Related Macular Degeneration Introduction

11.4.4 Alimera Science Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.4.5 Alimera Science Recent Development

11.5 Phio Pharmaceuticals

11.5.1 Phio Pharmaceuticals Company Details

11.5.2 Phio Pharmaceuticals Business Overview

11.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Introduction

11.5.4 Phio Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.5.5 Phio Pharmaceuticals Recent Development

11.6 Ocumension Therapeutics

11.6.1 Ocumension Therapeutics Company Details

11.6.2 Ocumension Therapeutics Business Overview

11.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Introduction

11.6.4 Ocumension Therapeutics Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.6.5 Ocumension Therapeutics Recent Development

11.7 Belite Bio

11.7.1 Belite Bio Company Details

11.7.2 Belite Bio Business Overview

11.7.3 Belite Bio Dry Age-Related Macular Degeneration Introduction

11.7.4 Belite Bio Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.7.5 Belite Bio Recent Development

11.8 Kubota Vision

11.8.1 Kubota Vision Company Details

11.8.2 Kubota Vision Business Overview

11.8.3 Kubota Vision Dry Age-Related Macular Degeneration Introduction

11.8.4 Kubota Vision Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.8.5 Kubota Vision Recent Development

11.9 Iveric Bio

11.9.1 Iveric Bio Company Details

11.9.2 Iveric Bio Business Overview

11.9.3 Iveric Bio Dry Age-Related Macular Degeneration Introduction

11.9.4 Iveric Bio Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.9.5 Iveric Bio Recent Development

11.10 Eyestem Research

11.10.1 Eyestem Research Company Details

11.10.2 Eyestem Research Business Overview

11.10.3 Eyestem Research Dry Age-Related Macular Degeneration Introduction

11.10.4 Eyestem Research Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.10.5 Eyestem Research Recent Development

11.11 Y2 Solution

11.11.1 Y2 Solution Company Details

11.11.2 Y2 Solution Business Overview

11.11.3 Y2 Solution Dry Age-Related Macular Degeneration Introduction

11.11.4 Y2 Solution Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.11.5 Y2 Solution Recent Development

11.12 Stealth Biotherapeutics

11.12.1 Stealth Biotherapeutics Company Details

11.12.2 Stealth Biotherapeutics Business Overview

11.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Introduction

11.12.4 Stealth Biotherapeutics Revenue in Dry Age-Related Macular Degeneration Business (2020-2025)

11.12.5 Stealth Biotherapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Santen Pharmaceuticals

Allergan plc

Bausch Health

Alimera Science

Phio Pharmaceuticals

IVERIC bio

Stealth Biotherapeutics

Ocumension Therapeutics

Belite Bio

Kubota Vision

Eyestem Research

Y2 Solution

List of Tables

Table 1. Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Injectables

Table 4. Global Dry Age-Related Macular Degeneration Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Dry Age-Related Macular Degeneration Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Dry Age-Related Macular Degeneration Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Dry Age-Related Macular Degeneration Market Share by Region (2020-2025)

Table 8. Global Dry Age-Related Macular Degeneration Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Dry Age-Related Macular Degeneration Market Share by Region (2026-2031)

Table 10. Dry Age-Related Macular Degeneration Market Trends

Table 11. Dry Age-Related Macular Degeneration Market Drivers

Table 12. Dry Age-Related Macular Degeneration Market Challenges

Table 13. Dry Age-Related Macular Degeneration Market Restraints

Table 14. Global Dry Age-Related Macular Degeneration Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Dry Age-Related Macular Degeneration Market Share by Players (2020-2025)

Table 16. Global Top Dry Age-Related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2024)

Table 17. Ranking of Global Top Dry Age-Related Macular Degeneration Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Dry Age-Related Macular Degeneration Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Dry Age-Related Macular Degeneration, Headquarters and Area Served

Table 20. Global Key Players of Dry Age-Related Macular Degeneration, Product and Application

Table 21. Global Key Players of Dry Age-Related Macular Degeneration, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Dry Age-Related Macular Degeneration Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Dry Age-Related Macular Degeneration Revenue Market Share by Type (2020-2025)

Table 25. Global Dry Age-Related Macular Degeneration Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Dry Age-Related Macular Degeneration Revenue Market Share by Type (2026-2031)

Table 27. Global Dry Age-Related Macular Degeneration Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Dry Age-Related Macular Degeneration Revenue Market Share by Application (2020-2025)

Table 29. Global Dry Age-Related Macular Degeneration Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Dry Age-Related Macular Degeneration Revenue Market Share by Application (2026-2031)

Table 31. North America Dry Age-Related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Dry Age-Related Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Dry Age-Related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Dry Age-Related Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Dry Age-Related Macular Degeneration Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Dry Age-Related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Dry Age-Related Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)

Table 46. Santen Pharmaceuticals Company Details

Table 47. Santen Pharmaceuticals Business Overview

Table 48. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product

Table 49. Santen Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 50. Santen Pharmaceuticals Recent Development

Table 51. Allergan Company Details

Table 52. Allergan Business Overview

Table 53. Allergan Dry Age-Related Macular Degeneration Product

Table 54. Allergan Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 55. Allergan Recent Development

Table 56. Bausch Health Company Details

Table 57. Bausch Health Business Overview

Table 58. Bausch Health Dry Age-Related Macular Degeneration Product

Table 59. Bausch Health Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 60. Bausch Health Recent Development

Table 61. Alimera Science Company Details

Table 62. Alimera Science Business Overview

Table 63. Alimera Science Dry Age-Related Macular Degeneration Product

Table 64. Alimera Science Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 65. Alimera Science Recent Development

Table 66. Phio Pharmaceuticals Company Details

Table 67. Phio Pharmaceuticals Business Overview

Table 68. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product

Table 69. Phio Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 70. Phio Pharmaceuticals Recent Development

Table 71. Ocumension Therapeutics Company Details

Table 72. Ocumension Therapeutics Business Overview

Table 73. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product

Table 74. Ocumension Therapeutics Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 75. Ocumension Therapeutics Recent Development

Table 76. Belite Bio Company Details

Table 77. Belite Bio Business Overview

Table 78. Belite Bio Dry Age-Related Macular Degeneration Product

Table 79. Belite Bio Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 80. Belite Bio Recent Development

Table 81. Kubota Vision Company Details

Table 82. Kubota Vision Business Overview

Table 83. Kubota Vision Dry Age-Related Macular Degeneration Product

Table 84. Kubota Vision Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 85. Kubota Vision Recent Development

Table 86. Iveric Bio Company Details

Table 87. Iveric Bio Business Overview

Table 88. Iveric Bio Dry Age-Related Macular Degeneration Product

Table 89. Iveric Bio Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 90. Iveric Bio Recent Development

Table 91. Eyestem Research Company Details

Table 92. Eyestem Research Business Overview

Table 93. Eyestem Research Dry Age-Related Macular Degeneration Product

Table 94. Eyestem Research Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 95. Eyestem Research Recent Development

Table 96. Y2 Solution Company Details

Table 97. Y2 Solution Business Overview

Table 98. Y2 Solution Dry Age-Related Macular Degeneration Product

Table 99. Y2 Solution Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 100. Y2 Solution Recent Development

Table 101. Stealth Biotherapeutics Company Details

Table 102. Stealth Biotherapeutics Business Overview

Table 103. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product

Table 104. Stealth Biotherapeutics Revenue in Dry Age-Related Macular Degeneration Business (2020-2025) & (US$ Million)

Table 105. Stealth Biotherapeutics Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Dry Age-Related Macular Degeneration Picture

Figure 2. Global Dry Age-Related Macular Degeneration Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Dry Age-Related Macular Degeneration Market Share by Type: 2024 VS 2031

Figure 4. Oral Features

Figure 5. Injectables Features

Figure 6. Global Dry Age-Related Macular Degeneration Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Dry Age-Related Macular Degeneration Market Share by Application: 2024 VS 2031

Figure 8. Above 40 Years Case Studies

Figure 9. Above 60 Years Case Studies

Figure 10. Above 75 Years Case Studies

Figure 11. Dry Age-Related Macular Degeneration Report Years Considered

Figure 12. Global Dry Age-Related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Dry Age-Related Macular Degeneration Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Dry Age-Related Macular Degeneration Market Share by Region: 2024 VS 2031

Figure 15. Global Dry Age-Related Macular Degeneration Market Share by Players in 2024

Figure 16. Global Top Dry Age-Related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Dry Age-Related Macular Degeneration Revenue in 2024

Figure 18. North America Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Dry Age-Related Macular Degeneration Market Share by Country (2020-2031)

Figure 20. United States Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Dry Age-Related Macular Degeneration Market Share by Country (2020-2031)

Figure 24. Germany Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Dry Age-Related Macular Degeneration Market Share by Region (2020-2031)

Figure 32. China Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Dry Age-Related Macular Degeneration Market Share by Country (2020-2031)

Figure 40. Mexico Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Dry Age-Related Macular Degeneration Market Share by Country (2020-2031)

Figure 44. Turkey Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Dry Age-Related Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Santen Pharmaceuticals Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 48. Allergan Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 49. Bausch Health Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 50. Alimera Science Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 51. Phio Pharmaceuticals Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 52. Ocumension Therapeutics Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 53. Belite Bio Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 54. Kubota Vision Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 55. Iveric Bio Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 56. Eyestem Research Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 57. Y2 Solution Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 58. Stealth Biotherapeutics Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Macular Edema and Macular Degeneration Market Research Report 2025

Global Ophthalmology for Age related Macular Degeneration Diseases Market Research Report 2024

Global Ophthalmology Disorders Drug Market Insights Forecast to 2030

Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024

Global Wet Macular Degeneration Market Research Report 2024

Global Geographic Atrophy Market Research Report 2025

Geographic Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Retinal Disorders Treatment Market Research Report 2024

Cystoid Edema Clinical Trials Market

Global Macular Pucker Treatment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions